Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes
Blood Vessels, Thrombosis & Hemostasis
· Elsevier
Аннотация
Publication date: August 2026 Source: Blood Vessels, Thrombosis & Hemostasis, Volume 3, Issue 3 Author(s): Jinelis Santiago-Beniquez, Avraham Adelman, Eunice Im, Anil Patel, Nikita Chapurin, Christina Eagan, Ali Ataya, Marc Zumberg, Jennifer K. Mulligan, Carl Atkinson, Brian C. Lobo, Jeb M. Justice
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Хирургия»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes. // Blood Vessels, Thrombosis & Hemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all
Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes. Blood Vessels, Thrombosis & Hemostasis. https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all
“Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes.” Blood Vessels, Thrombosis & Hemostasis.
@article{article93441,
title = {Doxycycline for epistaxis in hereditary hemorrhagic telangiectasia: genotype-stratified outcomes},
journal = {Blood Vessels, Thrombosis \& Hemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2950327226000586?dgcid=rss_sd_all}
}